Literature DB >> 29381471

Assessment of bone turnover in osteoporosis: harmonization of the total testing process.

Samuel Vasikaran1.   

Abstract

Entities:  

Keywords:  bone markers; bone turnover; fracture risk; harmonization; monitoring treatment; standards

Mesh：

Substances：

Year:  2018        PMID： 29381471     DOI： 10.1515/cclm-2017-1109

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  3 in total

1.  Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway.

Authors:  Yongfeng Zhang; Xin Liu; Yangyang Li; Minkai Song; Yutong Li; Anhui Yang; Yaqin Zhang; Di Wang; Min Hu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 2.  Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.

Authors:  Byung-Ho Yoon; Woojin Yu
Journal:  J Bone Metab       Date:  2018-05-31

3.  Effects of Rambutan Peel (Nepheliumlappaceum) PhenolicExtract on RANKL-Induced Differentiation of RAW264.7 Cells into Osteoclasts and Retinoic Acid-Induced Osteoporosis in Rats.

Authors:  Yongliang Zhuang; Xiaodong Sun; Bingtong Liu; Hu Hou; Yun Sun
Journal:  Nutrients       Date:  2020-03-25       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.